Jeff Bezos has had quite a hectic week, having just concluded his third venture capital investment in a promising artificial intelligence startup. This time, the recipient of Bezos’s largesse is a ...

Jefferies London Healthcare Conference 2025 November 20, 2025 7:30 AM ESTCompany ParticipantsJames Hippel - Executive VP ...

RBC Capital analyst Leonid Timashev upgraded Design Therapeutics (DSGN) to Outperform from Sector Perform with a price target of $13, up from $6.

The Jacobs School of Medicine and Biomedical Sciences’ use of artificial intelligence (AI) is transforming its medical research landscape by accelerating discovery, improving accuracy and enabling ...

Enanta Pharmaceuticals, Inc.'s strong pipeline, positive RSV drug data, and solid cash position drive growth. Click for my ...

A mini-peptide has been created that delays the early damage caused by Parkinson's disease and promises a way to slow down ...

Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...

Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.

Kinesin-1 is a dynamic heterotetrameric assembly of two heavy and two light chains (KHC and KLC) that mediates microtubule-based intracellular transport of many different cargoes. The complex adopts a ...

During the flat design boom of the 2010s, blocky sans-serif fonts were everywhere. Crisp, clean text adorned websites and ...

Spanish startup MOA Foodtech has unveiled the MOA Box, a turkey service for companies to create ingredients from food waste ...

Could siloed priorities be slowing the protein transition? A Dutch research project, Pulsating, is uniting breeders, farmers, ...